lexiara

anx_II__para_3__continuation__13

the producer must provide relevant information about the antigen and its formulation into vaccine for consideration by the CCI.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.